{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:39:12Z","timestamp":1790203152849,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["R01MH107126"],"award-info":[{"award-number":["R01MH107126"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00213-020-05566-0","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T06:02:41Z","timestamp":1590818561000},"page":"2695-2707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Novel, non-nitrocatechol catechol-O-methyltransferase inhibitors modulate dopamine neurotransmission in the frontal cortex and improve cognitive flexibility"],"prefix":"10.1007","volume":"237","author":[{"given":"Spencer","family":"Byers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid P.","family":"Buchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"DePasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kolobova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Akuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon C.","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Barrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-6729","authenticated-orcid":false,"given":"Gregory V.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,30]]},"reference":[{"key":"5566_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1471-4159.1992.tb08907.x","volume":"59","author":"E Acquas","year":"1992","unstructured":"Acquas E, Carboni E, de Ree RH, Da Prada M, Di Chiara G (1992) Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592. J Neurochem 59:326\u2013330","journal-title":"J Neurochem"},{"key":"5566_CR2","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.npp.1301227","volume":"32","author":"JA Apud","year":"2007","unstructured":"Apud JA, Mattay V, Chen J, Kolachana BS, Callicott JH, Rasetti R, Alce G, Iudicello JE, Akbar N, Egan MF, Goldberg TE, Weinberger DR (2007) Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology 32:1011\u20131020","journal-title":"Neuropsychopharmacology"},{"key":"5566_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2165\/00023210-200721070-00002","volume":"21","author":"JA Apud","year":"2007","unstructured":"Apud JA, Weinberger DR (2007) Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors. CNS Drugs 21:535\u2013557","journal-title":"CNS Drugs"},{"key":"5566_CR4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0021-9258(18)64731-3","volume":"233","author":"J Axelrod","year":"1958","unstructured":"Axelrod J, Tomchick R (1958) Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702\u2013705","journal-title":"J Biol Chem"},{"key":"5566_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/jnnp-2017-317459","volume":"89","author":"E Beeldman","year":"2018","unstructured":"Beeldman E, Raaphorst J, Klein Twennaar M, Govaarts R, Pijnenburg YAL, de Haan RJ, de Visser M, Schmand BA (2018) The cognitive profile of behavioural variant FTD and its similarities with ALS: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89:995\u20131002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5566_CR6","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1523\/JNEUROSCI.20-11-04320.2000","volume":"20","author":"JM Birrell","year":"2000","unstructured":"Birrell JM, Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20:4320\u20134324","journal-title":"J Neurosci"},{"key":"5566_CR7","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.1021\/acs.jmedchem.8b01126","volume":"61","author":"I Buchler","year":"2018","unstructured":"Buchler I, Akuma D, Au VQ, Carr G, de Leon P, DePasquale M, Ernst G, Huang Y, Kimos M, Kolobova A, Poslusney MS, Wei H, Swinnen D, Montel F, Moureau F, Jigorel E, Schulze MS, Wood M, Barrow JC (2018) Optimization of 8-hydroxyquinolines as inhibitors of catechol O-methyltransferase. J Med Chem. 61:9647\u20139665","journal-title":"J Med Chem."},{"key":"5566_CR8","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00213-018-4845-4","volume":"235","author":"IGM Cameron","year":"2018","unstructured":"Cameron IGM, Wallace DL, Al-Zughoul A, Kayser AS, D'Esposito M (2018) Effects of tolcapone and bromocriptine on cognitive stability and flexibility. Psychopharmacology (Berl) 235:1295\u20131305","journal-title":"Psychopharmacology (Berl)"},{"key":"5566_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/425589","volume":"75","author":"J Chen","year":"2004","unstructured":"Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807\u2013821","journal-title":"Am J Hum Genet"},{"key":"5566_CR10","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1037\/0735-7044.110.5.872","volume":"110","author":"R Dias","year":"1996","unstructured":"Dias R, Robbins TW, Roberts AC (1996) Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav Neurosci 110:872\u2013886","journal-title":"Behav Neurosci"},{"key":"5566_CR11","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.1073\/pnas.111134598","volume":"98","author":"MF Egan","year":"2001","unstructured":"Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT Val108\/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98:6917\u20136922","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5566_CR12","doi-asserted-by":"crossref","unstructured":"Ernst G, Akuma D, Au V, Buchler IP, Byers S, Carr GV, Defays S, de Leon P, Demaude T, DePasquale M, Durieu V, Huang Y, Jigorel E, Kimos M, Kolobova A, Montel F, Moureau F, Poslusney M, Swinnen D, Vandergeten M-C, Van houtvin N, Wei H, White N, Wood M, Barrow JC (2019) Synthesis and evaluation of bicyclic hydroxypyridones as inhibitors of Catechol-O-Methyltransferase. ACS Med. Chem. Lett. 10(11):1573\u20131578","DOI":"10.1021\/acsmedchemlett.9b00345"},{"key":"5566_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s11682-014-9338-4","volume":"9","author":"CL Gallagher","year":"2015","unstructured":"Gallagher CL, Bell B, Palotti M, Oh J, Christian BT, Okonkwo O, Sojkova J, Buyan-Dent L, Nickles RJ, Harding SJ, Stone CK, Johnson SC, Holden JE (2015) Anterior cingulate dopamine turnover and behavior change in Parkinson\u2019s disease. Brain Imaging Behav 9:821\u2013827","journal-title":"Brain Imaging Behav"},{"key":"5566_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/BF01285556","volume":"104","author":"M Gasparini","year":"1997","unstructured":"Gasparini M, Fabrizio E, Bonifati V, Meco G (1997) Cognitive improvement during Tolcapone treatment in Parkinson\u2019s disease. J Neural Transm (Vienna) 104:887\u2013894","journal-title":"J Neural Transm (Vienna)"},{"key":"5566_CR15","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.euroneuro.2013.07.008","volume":"23","author":"JE Grant","year":"2013","unstructured":"Grant JE, Odlaug BL, Chamberlain SR, Hampshire A, Schreiber LR, Kim SW (2013) A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation. Eur Neuropsychopharmacol 23:1587\u20131596","journal-title":"Eur Neuropsychopharmacol"},{"key":"5566_CR16","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/brain\/awv104","volume":"138","author":"J Gratwicke","year":"2015","unstructured":"Gratwicke J, Jahanshahi M, Foltynie T (2015) Parkinson\u2019s disease dementia: a neural networks perspective. Brain 138:1454\u20131476","journal-title":"Brain"},{"key":"5566_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/B978-0-12-381326-8.00007-7","volume":"95","author":"K Haasio","year":"2010","unstructured":"Haasio K (2010) Toxicology and safety of COMT inhibitors. Int Rev Neurobiol 95:163\u2013189","journal-title":"Int Rev Neurobiol"},{"key":"5566_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fpsyt.2018.00091","volume":"9","author":"WY Hsu","year":"2018","unstructured":"Hsu WY, Lane HY, Lin CH (2018) Medications used for cognitive enhancement in patients with schizophrenia, bipolar disorder, Alzheimer\u2019s disease, and Parkinson\u2019s disease. Front Psychiatry 9:91","journal-title":"Front Psychiatry"},{"key":"5566_CR19","doi-asserted-by":"crossref","unstructured":"Jain R, Katic A (2016) Current and investigational medication delivery systems for treating attention-deficit\/hyperactivity disorder. Prim Care Companion CNS Disord 18","DOI":"10.4088\/PCC.16r01979"},{"key":"5566_CR20","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/j.1471-4159.2010.06889.x","volume":"114","author":"M Kaenmaki","year":"2010","unstructured":"Kaenmaki M, Tammimaki A, Myohanen T, Pakarinen K, Amberg C, Karayiorgou M, Gogos JA, Mannisto PT (2010) Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice. J Neurochem 114:1745\u20131755","journal-title":"J Neurochem"},{"key":"5566_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1001\/jamapsychiatry.2014.1281","volume":"71","author":"RS Keefe","year":"2014","unstructured":"Keefe RS (2014) Cognition and motivation as treatment targets in schizophrenia. JAMA Psychiatry 71:987\u2013988","journal-title":"JAMA Psychiatry"},{"key":"5566_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061839","volume":"8","author":"LM Laatikainen","year":"2013","unstructured":"Laatikainen LM, Sharp T, Harrison PJ, Tunbridge EM (2013) Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions. PLoS One 8:e61839","journal-title":"PLoS One"},{"key":"5566_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25:59\u201370","journal-title":"Eur J Neurol"},{"key":"5566_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00213-008-1342-1","volume":"202","author":"CC Lapish","year":"2009","unstructured":"Lapish CC, Ahn S, Evangelista LM, So K, Seamans JK, Phillips AG (2009) Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex. Psychopharmacology (Berl) 202:521\u2013530","journal-title":"Psychopharmacology (Berl)"},{"key":"5566_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/YPG.0000000000000018","volume":"24","author":"LO Lee","year":"2014","unstructured":"Lee LO, Prescott CA (2014) Association of the catechol-O-methyltransferase val158met polymorphism and anxiety-related traits: a meta-analysis. Psychiatr Genet 24:52\u201369","journal-title":"Psychiatr Genet"},{"key":"5566_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/cne.1092","volume":"432","author":"DA Lewis","year":"2001","unstructured":"Lewis DA, Melchitzky DS, Sesack SR, Whitehead RE, Auh S, Sampson A (2001) Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol 432:119\u2013136","journal-title":"J Comp Neurol"},{"key":"5566_CR27","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/0140-6736(93)90750-B","volume":"341","author":"P Limousin","year":"1993","unstructured":"Limousin P, Pollak P, Gervason-Tournier CL, Hommel M, Perret JE (1993) Ro 40-7592, a COMT inhibitor, plus levodopa in Parkinson\u2019s disease. Lancet 341:1605","journal-title":"Lancet"},{"key":"5566_CR28","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1021\/bi00013a008","volume":"34","author":"T Lotta","year":"1995","unstructured":"Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202\u20134210","journal-title":"Biochemistry"},{"key":"5566_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jneumeth.2012.09.013","volume":"211","author":"MY Mahat","year":"2012","unstructured":"Mahat MY, Fakrudeen Ali Ahamed N, Chandrasekaran S, Rajagopal S, Narayanan S, Surendran N (2012) An improved method of transcutaneous cisterna magna puncture for cerebrospinal fluid sampling in rats. J Neurosci Methods 211:272\u2013279","journal-title":"J Neurosci Methods"},{"key":"5566_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1176\/appi.ajp.159.4.652","volume":"159","author":"AK Malhotra","year":"2002","unstructured":"Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D (2002) A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159:652\u2013654","journal-title":"Am J Psychiatry"},{"key":"5566_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0306-4522(02)00556-0","volume":"116","author":"M Matsumoto","year":"2003","unstructured":"Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM, Kleinman JE, Weinberger DR (2003) Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 116:127\u2013137","journal-title":"Neuroscience"},{"key":"5566_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.alcohol.2017.08.007","volume":"67","author":"AM McCane","year":"2018","unstructured":"McCane AM, DeLory MJ, Timm MM, Janetsian-Fritz SS, Lapish CC, Czachowski CL (2018) Differential COMT expression and behavioral effects of COMT inhibition in male and female Wistar and alcohol preferring rats. Alcohol 67:15\u201322","journal-title":"Alcohol"},{"key":"5566_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1478-811X-11-34","volume":"11","author":"J Meiser","year":"2013","unstructured":"Meiser J, Weindl D, Hiller K (2013) Complexity of dopamine metabolism. Cell Commun Signal 11:34","journal-title":"Cell Commun Signal"},{"key":"5566_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/bdi.12497","volume":"19","author":"KW Miskowiak","year":"2017","unstructured":"Miskowiak KW, Kjaerstad HL, Stottrup MM, Svendsen AM, Demant KM, Hoeffding LK, Werge TM, Burdick KE, Domschke K, Carvalho AF, Vieta E, Vinberg M, Kessing LV, Siebner HR, Macoveanu J (2017) The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder. Bipolar Disord 19:214\u2013224","journal-title":"Bipolar Disord"},{"key":"5566_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","volume":"22","author":"JA Moron","year":"2002","unstructured":"Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22:389\u2013395","journal-title":"J Neurosci"},{"key":"5566_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/1756285613512392","volume":"7","author":"T Muller","year":"2014","unstructured":"Muller T, Investigators TS (2014) Tolcapone addition improves Parkinson\u2019s disease associated nonmotor symptoms. Ther Adv Neurol Disord 7:77\u201382","journal-title":"Ther Adv Neurol Disord"},{"key":"5566_CR37","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1212\/01.wnl.0000180516.69442.95","volume":"65","author":"D Muslimovic","year":"2005","unstructured":"Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239\u20131245","journal-title":"Neurology"},{"key":"5566_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","volume":"67","author":"A Nieoullon","year":"2002","unstructured":"Nieoullon A (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol 67:53\u201383","journal-title":"Prog Neurobiol"},{"key":"5566_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jneumeth.2008.12.001","volume":"178","author":"R Nirogi","year":"2009","unstructured":"Nirogi R, Kandikere V, Mudigonda K, Bhyrapuneni G, Muddana N, Saralaya R, Benade V (2009) A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system. J Neurosci Methods 178:116\u2013119","journal-title":"J Neurosci Methods"},{"key":"5566_CR40","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.neuropharm.2011.04.025","volume":"62","author":"F Papaleo","year":"2012","unstructured":"Papaleo F, Lipska BK, Weinberger DR (2012) Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology 62:1204\u20131220","journal-title":"Neuropharmacology"},{"key":"5566_CR41","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.euroneuro.2015.10.005","volume":"25","author":"F Papaleo","year":"2015","unstructured":"Papaleo F, Sannino S, Piras F, Spalletta G (2015) Sex-dichotomous effects of functional COMT genetic variations on cognitive functions disappear after menopause in both health and schizophrenia. Eur Neuropsychopharmacol 25:2349\u20132363","journal-title":"Eur Neuropsychopharmacol"},{"key":"5566_CR42","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/BF00970600","volume":"20","author":"IA Paterson","year":"1995","unstructured":"Paterson IA, Davis BA, Durden DA, Juorio AV, Yu PH, Ivy G, Milgram W, Mendonca A, Wu P, Boulton AA (1995) Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain. Neurochem Res 20:1503\u20131510","journal-title":"Neurochem Res"},{"key":"5566_CR43","doi-asserted-by":"crossref","unstructured":"Popik P, Nikiforuk A (2015) Attentional set-shifting paradigm in the rat. Curr Protoc Neurosci 72: 9 51 1-13.","DOI":"10.1002\/0471142301.ns0951s72"},{"key":"5566_CR44","first-page":"171","volume":"40","author":"A Reches","year":"1984","unstructured":"Reches A, Fahn S (1984) Catechol-O-methyltransferase and Parkinson\u2019s disease. Adv Neurol 40:171\u2013179","journal-title":"Adv Neurol"},{"key":"5566_CR45","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1038\/npp.2014.29","volume":"39","author":"V Risbrough","year":"2014","unstructured":"Risbrough V, Ji B, Hauger R, Zhou X (2014) Generation and characterization of humanized mice carrying COMT158 Met\/Val alleles. Neuropsychopharmacology 39:1823\u20131832","journal-title":"Neuropsychopharmacology"},{"key":"5566_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1021\/cn200109w","volume":"3","author":"RG Robinson","year":"2012","unstructured":"Robinson RG, Smith SM, Wolkenberg SE, Kandebo M, Yao L, Gibson CR, Harrison ST, Polsky-Fisher S, Barrow JC, Manley PJ, Mulhearn JJ, Nanda KK, Schubert JW, Trotter BW, Zhao Z, Sanders JM, Smith RF, McLoughlin D, Sharma S, Hall DL, Walker TL, Kershner JL, Bhandari N, Hutson PH, Sachs NA (2012) Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates. ACS Chem Neurosci 3:129\u2013140","journal-title":"ACS Chem Neurosci"},{"key":"5566_CR47","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/cercor\/bhu053","volume":"25","author":"S Sannino","year":"2015","unstructured":"Sannino S, Gozzi A, Cerasa A, Piras F, Scheggia D, Manago F, Damiano M, Galbusera A, Erickson LC, De Pietri TD, Bifone A, Tsaftaris SA, Caltagirone C, Weinberger DR, Spalletta G, Papaleo F (2015) COMT genetic reduction produces sexually divergent effects on cortical anatomy and working memory in mice and humans. Cereb Cortex 25:2529\u20132541","journal-title":"Cereb Cortex"},{"key":"5566_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.109","volume":"7","author":"S Sannino","year":"2017","unstructured":"Sannino S, Padula MC, Manago F, Schaer M, Schneider M, Armando M, Scariati E, Sloan-Bena F, Mereu M, Pontillo M, Vicari S, Contarini G, Chiabrera C, Pagani M, Gozzi A, Eliez S, Papaleo F (2017) Adolescence is the starting point of sex-dichotomous COMT genetic effects. Transl Psychiatry 7:e1141","journal-title":"Transl Psychiatry"},{"key":"5566_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00213-010-1944-2","volume":"211","author":"A Tammimaki","year":"2010","unstructured":"Tammimaki A, Kaenmaki M, Kambur O, Kulesskaya N, Keisala T, Karvonen E, Garcia-Horsman JA, Rauvala H, Mannisto PT (2010) Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice. Psychopharmacology (Berl) 211:389\u2013401","journal-title":"Psychopharmacology (Berl)"},{"key":"5566_CR50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/dna.1993.12.253","volume":"12","author":"J Tenhunen","year":"1993","unstructured":"Tenhunen J, Salminen M, Jalanko A, Ukkonen S, Ulmanen I (1993) Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme. DNA Cell Biol 12:253\u2013263","journal-title":"DNA Cell Biol"},{"key":"5566_CR51","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/j.1432-1033.1994.tb19083.x","volume":"223","author":"J Tenhunen","year":"1994","unstructured":"Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I (1994) Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049\u20131059","journal-title":"Eur J Biochem"},{"issue":"Pt 3","key":"5566_CR52","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1042\/bj2960595","volume":"296","author":"J Tenhunen","year":"1993","unstructured":"Tenhunen J, Ulmanen I (1993) Production of rat soluble and membrane-bound catechol O-methyltransferase forms from bifunctional mRNAs. Biochem J 296(Pt 3):595\u2013600","journal-title":"Biochem J"},{"key":"5566_CR53","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1523\/JNEUROSCI.1124-04.2004","volume":"24","author":"EM Tunbridge","year":"2004","unstructured":"Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ (2004) Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24:5331\u20135335","journal-title":"J Neurosci"},{"key":"5566_CR54","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41386-018-0018-8","volume":"43","author":"A Valomon","year":"2018","unstructured":"Valomon A, Holst SC, Borrello A, Weigend S, Muller T, Berger W, Sommerauer M, Baumann CR, Landolt HP (2018) Effects of COMT genotype and tolcapone on lapses of sustained attention after sleep deprivation in healthy young men. Neuropsychopharmacology 43:1599\u20131607","journal-title":"Neuropsychopharmacology"},{"key":"5566_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tpb.2017.11.006","volume":"119","author":"M Wanneveich","year":"2018","unstructured":"Wanneveich M, Jacqmin-Gadda H, Dartigues JF, Joly P (2018) Projections of health indicators for chronic disease under a semi-Markov assumption. Theor Popul Biol 119:83\u201390","journal-title":"Theor Popul Biol"},{"key":"5566_CR56","unstructured":"Watkins P (2000) COMT inhibitors and liver toxicity. Neurology 55: S51-2; discussion S53-6."},{"key":"5566_CR57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fnbeh.2017.00195","volume":"11","author":"RL Wood","year":"2017","unstructured":"Wood RL, Worthington A (2017) Neurobehavioral abnormalities associated with executive dysfunction after traumatic brain injury. Front Behav Neurosci 11:195","journal-title":"Front Behav Neurosci"},{"key":"5566_CR58","doi-asserted-by":"publisher","first-page":"10196","DOI":"10.1523\/JNEUROSCI.0665-07.2007","volume":"27","author":"L Yavich","year":"2007","unstructured":"Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Mannisto PT (2007) Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 27:10196\u201310209","journal-title":"J Neurosci"},{"key":"5566_CR59","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1021\/acschemneuro.9b00395","volume":"10","author":"G Zhang","year":"2019","unstructured":"Zhang G, Buchler IP, DePasquale M, Wormald M, Liao G, Wei H, Barrow JC, Carr GV (2019) Development of a PC12 cell based assay for screening catechol-O-methyltransferase inhibitors. ACS Chem Neurosci 10:4221\u20134226","journal-title":"ACS Chem Neurosci"},{"key":"5566_CR60","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jns.2016.08.063","volume":"369","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Feng S, Nie K, Zhao X, Gan R, Wang L, Zhao J, Tang H, Gao L, Zhu R, Wang L, Zhang Y (2016) Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson\u2019s disease. J Neurol Sci 369:347\u2013353","journal-title":"J Neurol Sci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05566-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T19:15:09Z","timestamp":1622315709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05566-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,30]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5566"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05566-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/510040","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,30]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the local Animal Care and Use Committee and were in compliance with the <i>Guide for the Care and Use of Laboratory Animals<\/i>.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"IPB and JCB are inventors on patents that include the novel COMT inhibitors (WO2016123576 and WO2017091818). HLR, RSK, LP, and SCC are employees of RenaSci Ltd. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}